These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 3744014)
1. [Effectiveness of cytostatic therapy of polycythemia vera]. Kovaleva LG; Kho PI Gematol Transfuziol; 1986 Jul; 31(7):42-6. PubMed ID: 3744014 [No Abstract] [Full Text] [Related]
2. [Current aspects of the treatment of polycythemia vera under polyclinical conditions]. Osechenskaia GV; Krasiukova LI Probl Gematol Pereliv Krovi; 1978 Jan; 23(1):21-4. PubMed ID: 628661 [No Abstract] [Full Text] [Related]
3. Cytostatic treatment of polycythaemia rubra vera. Comparison of the effects of some cytostatics in 100 patients in a period of five years. Nagy G; Léhi M Haematologia (Budap); 1975; 9(3-4):283-6. PubMed ID: 181298 [TBL] [Abstract][Full Text] [Related]
4. Treatment by radiophosphorus versus busulfan in polycythemia vera: a randomized trial (E.O.R.T.C.'s) "leukemias and hematosarcomas" group. Recent Results Cancer Res; 1977; (62):104-9. PubMed ID: 341245 [No Abstract] [Full Text] [Related]
5. Busulfan versus 32P in polycythaemia vera. Zittoun R Drugs Exp Clin Res; 1986; 12(1-3):283-5. PubMed ID: 3525077 [TBL] [Abstract][Full Text] [Related]
6. Procarbazine (Natulan) and busulfan in the treatment of polycythemia vera. Penttilä O; Ikkala E Ann Med Intern Fenn; 1968; 57(2):99-101. PubMed ID: 5706392 [No Abstract] [Full Text] [Related]
7. Myelosuppression in polycythemia vera: chemotherapy or radiotherapy? Najean Y; Dresch C Blut; 1982 Jan; 44(1):1-5. PubMed ID: 7059686 [No Abstract] [Full Text] [Related]
8. Survival of patients with polycythemia vera on busulfan or 32P. Mathé G N Engl J Med; 1978 Feb; 298(5):279. PubMed ID: 619270 [No Abstract] [Full Text] [Related]
9. Polycythemia vera treated with -32p and myleran: development of chronic granulocytic leukemia with chromosomal abnormalities in one patient. Staven P; VAN DER Hagen CB; Vogt E; Sandnes K Clin Genet; 1975 Mar; 7(3):227-31. PubMed ID: 1056276 [TBL] [Abstract][Full Text] [Related]
10. [Results of busulfan (myleran) therapy of polycythemia vera]. Urasiński I; Mysik M Pol Arch Med Wewn; 1969 Apr; 42(4):661-7. PubMed ID: 5792045 [No Abstract] [Full Text] [Related]
11. [Treatment of polycythemia vera with dibromomannitol (author's transl)]. Yonemitsu H; Kanazawa S; Kondo H; Yamaguchi K; Okuda K; Shigeta H Rinsho Ketsueki; 1980 May; 21(5):587-91. PubMed ID: 6774132 [No Abstract] [Full Text] [Related]
13. Busulfan versus hydroxyurea in the treatment of polycythemia vera (PV) and essential thrombocythemia (ET). Brodsky I Am J Clin Oncol; 1998 Feb; 21(1):105-6. PubMed ID: 9499248 [No Abstract] [Full Text] [Related]
14. [Combined chemo-radionuclide therapy of cancer (complexotherapy)]. Czerniak P; Zari A Harefuah; 1971 Feb; 80(3):119-22. PubMed ID: 5099250 [No Abstract] [Full Text] [Related]
15. [Efficacious treatment of a fatal blood disease: polycythemia vera]. Sánchez Fayos J; Román Barbero A; Nevado Reviriego I Sangre (Barc); 1997 Jun; 42(3):215-8. PubMed ID: 9381264 [No Abstract] [Full Text] [Related]
16. Osmotic fragility changes of ACD blood units from polycythemic donors. Ben-David A; Gavendo S Transfusion; 1973; 13(5):320-3. PubMed ID: 4750181 [No Abstract] [Full Text] [Related]
17. Polycythemia vera: diagnosis and treatment 2002. Berlin NI Expert Rev Anticancer Ther; 2002 Jun; 2(3):330-6. PubMed ID: 12113056 [TBL] [Abstract][Full Text] [Related]
18. [Association of polycythemia vera and multiple myeloma. Presentation ofa new case and review of the literature]. Prósper F; Paloma MJ; Rifón J; Cuesta B; Hermida J; Rocha E Sangre (Barc); 1993 Dec; 38(6):497-9. PubMed ID: 8171387 [TBL] [Abstract][Full Text] [Related]
19. Patho-anatomical features of the bone marrow. Lennert K; Nagai K; Schwarze EW Clin Haematol; 1975 Jun; 4(2):331-51. PubMed ID: 1102191 [No Abstract] [Full Text] [Related]